← Browse by Condition
Medical Condition

metastatic lung non small cell carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT04762199 Phase 1
Recruiting

MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

Enrollment
69 pts
Location
United States
Sponsor
Emory University
View Trial →